International Society on Thrombosis and Haemostasis - 34th Congress, 2026 (ISTH) 11 - 15 July 2026

Mim8 (denecimig) prophylaxis in adults, adolescents and children with haemophilia A with or without inhibitors: Interim patient-reported outcomes from the long-term extension study (FRONTIER4)

Authors :

Cihan Ay¹, Sanjay Ahuja², Pratima Chowdary³, Meera Chitlur^4,5, Llenalia María García Fernández⁶, Kaan Kavakli⁷, Ilgiz Rakhmatullin⁸, Chandrakala Shanmukhaiah⁹, Jerzy Windyga¹⁰, Samya Obaji¹¹

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Rare Blood Disorders

Congress poster

Mim8

Search Science Hub

Are you a healthcare professional?

Mim8 (denecimig) prophylaxis in adults, adolescents and children with haemophilia A with or without inhibitors: Interim patient-reported outcomes from the long-term extension study (FRONTIER4)

Search Science Hub

Are you a healthcare professional?

Mim8 (denecimig) prophylaxis in adults, adolescents and children with haemophilia A with or without inhibitors: Interim patient-reported outcomes from the long-term extension study (FRONTIER4)​

Mim8 (denecimig) prophylaxis in adults, adolescents and children with haemophilia A with or without inhibitors: Interim patient-reported outcomes from the long-term extension study (FRONTIER4)